Dhanapalan Nagarathnam

Title: Dhanapalan Nagarathnam: Innovator in Pharmaceutical Chemistry

Introduction

Dhanapalan Nagarathnam is a notable inventor based in Marblehead, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective treatments for chronic diseases and cardiovascular conditions.

Latest Patents

Nagarathnam holds a patent for "Crystalline forms of 4-ethoxy-n-(2-methoxyethyl)-n-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5, 1-f][1,2,4]triazin-2-yl)benzenesulfonamide." This invention provides solid, crystalline forms of Compound I, which has the potential to treat, prevent, or reduce diseases related to high blood pressure. The methods described in the patent involve administering an effective amount of a crystalline form of Compound I to subjects in need.

Career Highlights

Nagarathnam is currently associated with Retension Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is instrumental in the pharmaceutical industry, contributing to innovative solutions for pressing health issues.

Collaborations

Some of his notable coworkers include Bridget McCarthy Cole and Enoch Kim, who collaborate with him on various projects within the company.

Conclusion

Dhanapalan Nagarathnam's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patent and ongoing work at Retension Pharmaceuticals, Inc. highlight his commitment to improving treatment options for chronic diseases.